Suicide and Chronic Traumatic Encephalopathy
Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
Abstract
For nearly 80 years, suicidality was not considered to be a core clinical feature of chronic traumatic encephalopathy (CTE). In recent years, suicide has been widely cited as being associated with CTE, and now depression has been proposed to be one of three core diagnostic features alongside cognitive impairment and anger control problems. This evolution of the clinical features has been reinforced by thousands of media stories reporting a connection between mental health problems in former athletes and military veterans, repetitive neurotrauma, and CTE. At present, the science underlying the causal assumption between repetitive neurotrauma, depression, suicide, and the neuropathology believed to be unique to CTE is inconclusive. Epidemiological evidence indicates that former National Football League players, for example, are at lower, not greater, risk for suicide than men in the general population. This article aims to discuss the critical issues and literature relating to these possible relationships.
Chronic traumatic encephalopathy (CTE) was originally conceptualized as a static and possibly progressive neurological disorder affecting some boxers who had a tremendous exposure to neurotrauma.1,2 In 1928, Martland1 described a “peculiar condition” affecting long-career boxers that appeared to be clearly neurological, in that it included gait disturbance, dysarthria, tremor, and cognitive impairment. Martland referred to this syndrome as “punch drunk,” and other authors termed it “traumatic encephalopathy,”3 “dementia pugilistica,”4 and “CTE.”5 For the next 40 years, the syndrome was only described in case studies. The first and only large study of CTE in 80 years (1929–2009) was conducted by Roberts2 and was published as a book in 1969. Roberts2 reviewed the case studies that had been published between 1929 and the late 1960s and reported that the boxers had fairly obvious neurological deficits. However, there was limited understanding of the clinical features and there was no information on the prevalence of the syndrome. Roberts began with a list of 16,781 retired boxers and obtained an age-stratified random sample of 250. Of those, 16 had died, nine emigrated, and one refused to participate in the study. Of the 16 who died, there were no confirmed cases of suicide, although there was one suspicious death associated with carbon monoxide poisoning. After clinically examining the 224 retired boxers, Roberts concluded that 11% had a mild form of the syndrome and 6% had severe problems. This remains the largest clinical study of possible CTE published to date.
Through the process of examining these 224 retired professional boxers, Roberts2 made some important observations. First, he established a statistical association between exposure and the clinical syndrome. For example, for boxers aged >50 years who had ≥150 fights, 50% had the syndrome compared with 7% who had <50 fights. Second, many of the boxers had neurological problems (e.g., speech or gait problems) toward the end of their careers while they were still active fighters. Third, he noted that many people with the syndrome had a static course, but a small number of others appeared to have a progressive course greater than expected from natural aging. Fourth, Roberts2 noted that some boxers had other health problems and neurological conditions that either co-occurred with the syndrome or were more likely to be the predominant underlying cause of the clinical symptoms (e.g., cerebrovascular disease). Finally, he discussed personality changes, social decline, and psychiatric problems in some former boxers, but he struggled to determine the extent to which they were caused primarily by the neurological syndrome. He did not consider depression or suicidality to be a clinical feature.
Approximately 40 years later, CTE was conceptualized in much broader terms. The clinical features described as characteristic of CTE are now broad and diverse, including headaches, anxiety, depression, suicidality, anger control problems, gambling problems, gait problems, dysarthric speech, mild cognitive impairment, motor neuron disease, and dementia.6–13 In fact, it was found that a person with no clinical symptoms could have CTE.7 The problem from a clinical perspective is that the neuropathology, even in small amounts, has been considered sufficient to diagnose the syndrome, even if there were few or no symptoms present. By comparison, this is tantamount to concluding that people with a small amount of neuropathology associated with Alzheimer’s disease or Parkinson’s disease have the disease, even if they appear clinically normal at that point in life. The situation has been further complicated by the implicit, and often explicit, assumption that any clinical feature present before death must be mostly caused by the neuropathology believed to be unique to CTE.6–13 As such, CTE, over the past few years, appears to have been woven into a Gordian knot.
In the published literature, between 1928 and 2009, suicide was not considered a clinical feature of CTE. In a 2009 review, McKee et al.6 identified 48 cases of CTE in the entire literature, carefully documented their clinical and neuropathological characteristics, and added three additional case studies. McKee et al.6 did not report suicide to be a clinical feature of CTE. In 2010, Omalu et al.14 published their third case of CTE in a former National Football League (NFL) player. With this work, Omalu et al.14 introduced the finding that suicidality was a prominent clinical feature of CTE. This conclusion appears to be based on the fact that suicide was the cause of death of two of the three cases examined by Omalu et al.14; however, the extent to which it was influenced by the extraordinary media coverage of all of the case studies during that period is unknown. In recent years, it has been asserted that suicide is a common clinical feature of CTE,7–13 although three review articles concluded that current scientific evidence does not support these assertions.15–17 Nonetheless, it is now common for clinicians and researchers to adopt the assumption that suicide is an established clinical feature of CTE.
In an epidemiological study reporting causes of death in former NFL players, nine completed suicide over the course of 47 years (1960–2007), a rate that is less than one-half of what is expected from men in the general population.18 Therefore, before 2007, the best available evidence indicated that former NFL players were at substantially lower risk for suicide than men in the general population. In stark contrast, the media reported that at least six current or former NFL players completed suicide in 2012 alone, all by self-inflicted gunshot wounds, suggesting a recent increase in the incidence of suicide in current and former NFL players. It is important to carefully consider and review the possible associations between repetitive neurotrauma, neuropathology, CTE, and suicide.
Neuropathology
In recent years, diverse types of macroscopic and microscopic neuropathology have been described as characteristic or as being associated with CTE, including 1) cavum septum pellucidi with fenestrations; 2) enlarged ventricles; 3) frontal and temporal atrophy, thinning of the hypothalamic floor, shrinkage of the mammillary bodies, pallor of the substantia nigra, hippocampal sclerosis, and reduction in brain mass; 4) localized neuronal and glial accumulations of phosphorylated tau involving perivascular areas of the cerebral cortex, sulcal depths, and with a preference for neurons within superficial cortical laminae; 5) multifocal axonal varicosities involving deep cortex and subcortical white matter; 6) variable and often absent beta-amyloid deposits; and 7) TAR DNA-binding protein 43–positive inclusions and neurites.6,11,19 Much of the above-described neuropathology, however, can be seen in association with aging and in other diseases such as Alzheimer’s disease, frontotemporal dementia, and progressive supranuclear palsy.20–22 It is becoming increasingly apparent that abnormal accumulation of p-tau in perivascular regions and depths of sulci is the most unique and specific neuropathological feature.7 The first National Institutes of Health–supported consensus workshop relating to defining the neuropathological criteria for CTE occurred in Boston on February 26–27, 2015, and the initial findings from this consensus group were presented and published online by the National Institute of Neurological Disorders and Stroke.23 The neuropathology considered pathognomonic of CTE, and necessary for diagnosis, is abnormal accumulation of tau in neurons and glia in an irregular, focal, perivascular distribution and at the depths of cortical sulci.
Risk Factors for Depression and Suicide in Men
There has been an assumption in the literature (and the media) that the neuropathology of CTE causes depression and increases the risk for suicide in former athletes and military veterans. However, risk factors for suicide in former NFL players and other collision sport athletes should be considered in the broader context of the risk for suicide in the general population. There is a vast amount of global literature on suicidal ideation, plans, attempts, and completed suicide in adolescents, adults, and older adults. Risk factors for suicidality (e.g., ideation and behavior) and completed suicide are diverse, extend far beyond depression, and include the following: 1) childhood adversities such as physical abuse, sexual abuse, or family violence24; 2) interpersonal or family conflict25; 3) financial difficulties26; 4) substance abuse27,28; 5) physical illnesses29 and poor general health30; 6) chronic pain31–33; 7) personality disorders34; 8) impulsivity and aggression35–37; 9) limited social connectedness38; and 10) hopelessness.39 Certain high-risk cognitive states are associated with suicidal ideation and suicidal behavior (see Brown and Green40 for a review). Examples include hopelessness41,42 and problem-solving deficits such as difficulty conceptualizing adaptive solutions to life problems.43 Perceived burdensomeness and thwarted belongingness (a belief that one does not have meaningful interpersonal relationships) might also be related to suicidal ideation and behavior in some people.44 Major interpersonal stressful life events might precipitate suicide attempts in adults with alcohol problems.45
Depression is a prominent risk factor for suicidal ideation and behavior. Depression is fairly common in men across their lifespan, and suicidality is a cardinal diagnostic feature of major depressive disorder.46 The 12-month prevalence of depression in men born in the United States is 13.9%, 12.4%, 10.1%, 7.8%, and 4.3% for those aged 25–34, 35–44, 45–54, 55–64, and 65–74 years, respectively. The lifetime prevalence of depression in men in these five age cohorts is 26.1%, 28.1%, 27.3%, 21.9%, and 15.9%, respectively.47 In general, depression is believed to arise from the cumulative effects48–50 of genetics,51–54 adverse events in childhood,55–58 and ongoing life stressors.59–62 Moreover, people with a variety of health problems and medical conditions (e.g., diabetes,63–65 cardiovascular and cerebrovascular disease,66–70 chronic headaches,71–74 hypothyroidism,75 chronic insomnia,76 low testosterone,77–79 obesity,80 stroke or small-vessel ischemic disease,81,82 Parkinson’s disease,83 and Alzheimer’s disease84) are at increased risk of having depression.
Chronic pain is bidirectionally associated with depression85–89; individuals with depression are more likely to have chronic pain and those with chronic pain are more likely to experience depression—and each condition might serve as a magnifier for the other. Hooley et al.33 proposed a theoretical model for how people with chronic pain are at increased risks for suicidal ideation and behavior. This model included a pathway involving a combination of depression, psychache (unbearable psychological pain), desire to escape physical pain, increased capability for suicide, sense of burdensomeness, and thwarted sense of belongingness.
The rate of chronic pain and opioid use in former NFL players is relatively high,90 and those retired players with depression and chronic pain also have greater life stress and financial difficulties.91 Researchers have reported that people seeking treatment for chronic pain have high rates of comorbid depression,92 and individuals with chronic pain are at increased risks for suicidal ideation93 and suicide.31 As such, retired football players with life stress, financial difficulty, chronic pain, and depression are likely at increased risk for suicidal ideation—and they might be at increased risks for suicide attempts and completed suicide. In a recent media-based anonymous survey of 763 retired NFL players, a large number reported having difficulty adjusting to life after football (61%), having difficulty finding employment (34%), struggling financially (51%), experiencing marital problems (48%), taking prescription painkillers (27%), and experiencing some degree of depression (31%).94
Importantly, it is well established that people who sustain traumatic brain injuries (TBIs) of all severities are at an increased risk of having depression.95–100 TBI is also a relative risk factor for suicidality101 and suicide,102,103 although the absolute risk is small. In a longitudinal epidemiological study of 218,300 individuals, TBI was independently related to an increased risk for completed suicide, those with moderate or severe TBIs were at greater risk (compared with those with mild TBIs), and individuals with depression or substance abuse problems were at the greatest risk.104 The rate of suicide in the epidemiological study was as follows: general population (0.03%), TBI and no psychiatric disorder (0.1%), TBI and a psychiatric disorder (1%), TBI and depression (1.5%), and TBI and substance abuse (1.6%).
Depression is also common among those with dementia; 25%−50% of these individuals experience depression at some point over the course of their illness.105,106 There are now numerous studies reporting a relationship between depression, mild cognitive impairment, and Alzheimer’s disease. Depression is the most frequently reported psychiatric disorder among individuals with mild cognitive impairment,107 with one in five people with mild cognitive impairment reporting moderate to high levels of depression.108 In one study, symptoms of depression were reported in 51% of patients with mild cognitive impairment seen in a rural memory clinic.109 There is some evidence that depression is associated with an increased risk for progression from mild cognitive impairment to Alzheimer’s disease,110–113 although not all studies have shown this relationship.114 Depressive symptoms in individuals suffering from mild cognitive impairment have also been associated with greater atrophy in brain regions associated with Alzheimer’s disease.115
In conclusion, survey research suggests that former NFL players might be at increased risk for depression.48,92 NFL players are not immune, of course, to depression manifesting for similar biopsychosocial reasons as it does in other men, or to the many other risk factors for suicide that are present in the general population. Therefore, depression and suicidality in former athletes, including NFL players, might be multifactorial in causation and may or may not relate to specific types of neuropathology such as region-specific depositions of abnormal hyperphosphorylated tau. Factors related to depression and suicidality in the general population are listed in Table 1. Future research is needed to determine whether regionally specific depositions of tau can be added to this list.
| Genetics | Diabetes |
|---|---|
| Childhood adversity | Chronic headaches |
| Substance abuse | Chronic pain |
| Personality disorder | Obesity |
| Impulsivity | Cardiovascular disease |
| Aggression | Cerebrovascular disease |
| High-risk cognitive states | Traumatic brain injury |
| Marital and family problems | Parkinson’s disease |
| Financial distress | Preclinical or early Alzheimer’s disease |
| Alzheimer’s disease |
a
All of the above-mentioned factors are related to depression or suicidality, but not necessarily both.
Causation and Comorbidity
The autopsy case studies and case series that have been published in the past few years describe a diverse range of clinical symptoms (including mental health problems), state that those clinical symptoms are “characteristic” of CTE, and state or imply that the predominant underlying cause of these clinical features is delayed-onset, progressive, degenerative neuropathology. It will be a major challenge to test this causal theory because there has been a conflation of a broad range of neuropathology with a broad range of clinical symptoms reported by family members before a person’s death (i.e., they co-occur; therefore, they must be unidirectionally causally related), and the conflation is potentially magnified and reinforced by known comorbidities that are present in the general population. Simply put, some of the symptoms and problems that have been attributed to the neuropathology of CTE in the case studies presented in the literature in the past few years are known to co-occur in men in the general population who do not have exposure to repetitive neurotrauma and who do not have CTE. This is especially true for depression, anxiety, chronic pain, chronic headaches, substance abuse, impulsivity, irritability and aggression, and mild cognitive impairment.
Depression is a good example of a condition that has behavioral comorbidities that resemble modern CTE. Authors of several lay and academic books suggest that men who are depressed are often irritable, angry, and aggressive—and they engage in risky behaviors involving sex, alcohol, drugs, and gambling.116,117 Researchers have also reported that anger118 and irritability119,120 are associated with depression. Compared with women, men with depression have greater irritability, have lower impulse control, are more likely to overreact to minor annoyances and have anger attacks, and are more likely to abuse alcohol and drugs.121,122 Therefore, many of the clinical features attributed to CTE are actually comorbid in men with depression who do not have a history of repetitive neurotrauma.
There are five basic models for conceptualizing comorbidity. First, the comorbidity might be spurious in that it arose by coincidence or ascertainment bias. Without question, the former athletes and NFL players who have been examined at autopsy for CTE are highly selected and nonrepresentative and a disproportionate number have suicide as their cause of death. Thus, the ascertainment bias issue as a contributor to the assumed clinical-neuropathological associations in CTE is present and very important to consider and study. A second model of comorbidity is that the comorbidity might be unidirectional in that one condition causes another. Third, there might be a bidirectional causal relationship between the two conditions. Examples of relevant bidirectional causal relationships reported in the literature include depression and chronic pain,85–89 migraine and depression,73,123 depression and marital problems,124–126 and depression and alcohol dependence.127 Fourth, the two conditions might be comorbid due to shared underlying risk factors (genetic, environmental, or both). Depression and anxiety are bidirectionally related, but they are also comorbid because they share both environmental (e.g., childhood adversity and current life stressors) and genetic risk factors. Finally, genetic and/or environmental risk factors might produce a state of neurobiology that underlies both of the related conditions. To advance knowledge in CTE, we must carefully consider and try to better understand comorbidities.
Conclusions
The clinical syndrome of CTE, as described in recent years in retired athletes, departs substantially from descriptions of the syndrome from 1929 to 2005, by having a particular emphasis on depression and suicide. It is essential to appreciate that the causes of suicidal ideation, attempts, and completed suicide are complex, multifactorial, and difficult to predict in individual cases. In the general population, there are many biopsychosocial risk factors for depression and/or suicidality, such as genetics, adverse events in childhood, personality disorders, life and financial stressors, marital and family problems, limited social connectedness, hopelessness, substance abuse, impulsivity, aggression, chronic pain, chronic insomnia, chronic headaches, diabetes, cardiovascular and cerebrovascular disease, hypothyroidism, low testosterone, TBI, mild cognitive impairment, and Alzheimer’s disease. The extent to which one or more of those factors is related to depression and/or suicidality in individuals can be difficult to determine—and it is usually assumed that the underlying cause of both depression and suicidality is multifactorial in most people. A simplified model for risk for suicide in men is presented in Figure 1.
Maroon et al.17 reported that there were no cases of suicide in association with CTE before 2002. The rate of suicide in former NFL players, based on an epidemiological study tracking causes of death between 1960 and 2007, was less than one-half of what was expected from men in the general population.18 In the first review of all known cases of CTE,6 suicide was not considered a feature of the disease. Therefore, until recently, former NFL players appeared to be at substantially lower risk for suicide than men in the general population.
In the recent literature, it has been asserted and assumed that suicidality and completed suicide are common clinical features of CTE. The extent to which this belief has been reinforced in the general public and the medical and scientific community by thousands of media stories is unknown. However, the science underlying the assertions and assumptions that suicide is caused in whole or part by the neuropathology of CTE, or that it is a core clinical feature of CTE, is extremely limited, inconclusive, and, in fact, contradictory. Therefore, it is currently premature to assume that people with the neuropathology believed to be characteristic and unique to CTE are at an increased risk for suicide. This remains extremely difficult to study because as of 2015, there are no agreed-upon and validated clinical (or neuropathological) diagnostic criteria for CTE. As such, the disease cannot be reliably or accurately diagnosed in a living person.
Future studies relating to suicidal ideation, suicide attempts, and completed suicide in former athletes—those with and without a history of repetitive neurotrauma—are needed to determine whether neuropathology specific to repetitive neurotrauma can be added to the list of known risk factors for completed suicide. In addition, given the thousands of media stories relating to contact sports and CTE, it might be important to examine whether media coverage has had an adverse psychological effect on retired athletes, and whether repeated exposure to news stories elicits or reinforces suicidal ideation in some at-risk athletes. There are many studies relating to “contagion”128 and the influence of the media on suicidal behavior.129–132 As such, there are several mechanisms by which the media coverage reporting a causal relationship between contact sports, CTE, and suicide could be contributing to psychological distress in former athletes. Finally, although it is difficult to study directly, it might be possible to indirectly study whether the diagnosis or misdiagnosis of CTE by a health care provider could have iatrogenic effects in regard to suicidal ideation. For older adults, concerns have been expressed in the literature relating to early (e.g., preclinical) diagnosis of dementia and whether that might cause or contribute to depression or suicidality in some people,133,134 although some researchers have reported that the risk for depression or suicidality after receiving a diagnosis in those with mild to moderate Alzheimer’s disease is small.135 Living with an incurable neurological disease, such as multiple sclerosis, can be extraordinarily stressful and presents tremendous uncertainties in a person’s life,136,137 and some people with progressive neurodegenerative diseases, such as Huntington’s disease, perceive suicide as a viable option for them given the realities of their future.138 Moreover, in a survey of adults in the general population and U.S. veterans, 60% and 69%, respectively, said that a person has a right to commit suicide if he or she has an incurable disease.139
In conclusion, surveys have revealed that a substantial minority of former NFL players have mental health problems.47,91,140 Future research is needed to determine the extent to which abnormal tau deposition in the brains of former athletes is 1) progressive, 2) the driver of diverse clinical symptoms, and 3) a unique contributor to suicidal ideation and behavior. However, conceptualizing suicide as being the result of small focal epicenters of tau, or a progressive degenerative tauopathy, is currently scientifically premature, overly simplistic, and potentially fatalistic. It is important for health care providers to appreciate that there are multiple underlying biopsychosocial causes for mental health problems in former athletes—and these mental health problems might improve substantially with treatment. This reinforces the pressing need to provide evidence-based mental health treatment to those who are experiencing depression, substance abuse problems, and life stressors.
References
1.
Martland HS: Punch drunk. J Am Med Assoc 1928; 19:1103–1107
2.
Roberts A: Brain Damage in Boxers: A Study of Prevalence of Traumatic Encephalopathy Among Ex-Professional Boxers. London, Pitman Medical Scientific Publishing Co., 1969
3.
Parker HL: Traumatic encephalopathy (‘punch drunk’) of professional pugilists. J Neurol Psychopathol 1934; 15:20–28
4.
Millspaugh JA: Dementia pugilistica. U S Nav Med Bull 1937; 35:297–303
5.
Critchley M: Punch-Drunk Syndromes: The Chronic Traumatic Encephalopathy of Boxers. Edited by Hommage à Clovis Vincent. Paris, Maloine, 1949
6.
McKee AC, Cantu RC, Nowinski CJ, et al: Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 2009; 68:709–735
7.
McKee AC, Stern RA, Nowinski CJ, et al: The spectrum of disease in chronic traumatic encephalopathy. Brain 2013; 136:43–64
8.
Stern RA, Daneshvar DH, Baugh CM, et al: Clinical presentation of chronic traumatic encephalopathy. Neurology 2013; 81:1122–1129
9.
Gavett BE, Stern RA, McKee AC: Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma. Clin Sports Med 2011; 30:179–188, xi
10.
Stern RA, Riley DO, Daneshvar DH, et al: Long-term consequences of repetitive brain trauma: chronic traumatic encephalopathy. PM R 2011; 3(Suppl 2):S460–S467
11.
Baugh CM, Stamm JM, Riley DO, et al: Chronic traumatic encephalopathy: neurodegeneration following repetitive concussive and subconcussive brain trauma. Brain Imaging Behav 2012; 6:244–254
12.
Omalu BI, Bailes J, Hammers JL, et al: Chronic traumatic encephalopathy, suicides and parasuicides in professional American athletes: the role of the forensic pathologist. Am J Forensic Med Pathol 2010; 31:130–132
13.
Omalu B: Chronic traumatic encephalopathy. Prog Neurol Surg 2014; 28:38–49
14.
Omalu BI, Hamilton RL, Kamboh MI, et al: Chronic traumatic encephalopathy (CTE) in a National Football League Player: case report and emerging medicolegal practice questions. J Forensic Nurs 2010; 6:40–46
15.
Iverson GL: Chronic traumatic encephalopathy and risk of suicide in former athletes. Br J Sports Med 2014; 48:162–165
16.
Wortzel HS, Shura RD, Brenner LA: Chronic traumatic encephalopathy and suicide: a systematic review. BioMed Res Int 2013; 2013:424280
17.
Maroon JC, Winkelman R, Bost J, et al: Chronic traumatic encephalopathy in contact sports: a systematic review of all reported pathological cases. PLoS One 2015; 10:e0117338
18.
Baron SL, Hein MJ, Lehman E, et al: Body mass index, playing position, race, and the cardiovascular mortality of retired professional football players. Am J Cardiol 2012; 109:889–896
19.
Gavett BE, Cantu RC, Shenton M, et al: Clinical appraisal of chronic traumatic encephalopathy: current perspectives and future directions. Curr Opin Neurol 2011; 24:525–531
20.
Castellani RJ, Perry G, Iverson GL: Chronic effects of mild neurotrauma: putting the cart before the horse? J Neuropathol Exp Neurol 2015; 74:493–499
21.
Davis GA, Castellani RJ, McCrory P: Neurodegeneration and sport. Neurosurgery 2015; 76:643–655, discussion 655–656
22.
Iverson GL, Gardner AJ, McCrory P, et al: A critical review of chronic traumatic encephalopathy. Neurosci Biobehav Rev 2015; 56:276–293
23.
National Institute of Neurological Disorders and Stroke: Report From the First NIH Consensus Conference to Define the Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy, 2015. Bethesda, MD, National Institute of Neurological Disorders and Stroke (www.ninds.nih.gov/research/tbi/ReportFirstNIHConsensusConference.htm)
24.
Bruffaerts R, Demyttenaere K, Borges G, et al: Childhood adversities as risk factors for onset and persistence of suicidal behaviour. Br J Psychiatry 2010; 197:20–27
25.
Foster T: Adverse life events proximal to adult suicide: a synthesis of findings from psychological autopsy studies. Arch Suicide Res 2011; 15:1–15
26.
Richardson T, Elliott P, Roberts R: The relationship between personal unsecured debt and mental and physical health: a systematic review and meta-analysis. Clin Psychol Rev 2013; 33:1148–1162
27.
Nock MK, Hwang I, Sampson NA, et al: Mental disorders, comorbidity and suicidal behavior: results from the National Comorbidity Survey Replication. Mol Psychiatry 2010; 15:868–876
28.
Wilcox HC, Conner KR, Caine ED: Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies. Drug Alcohol Depend 2004; 76(Suppl):S11–S19
29.
Scott KM, Hwang I, Chiu WT, et al: Chronic physical conditions and their association with first onset of suicidal behavior in the world mental health surveys. Psychosom Med 2010; 72:712–719
30.
Conwell Y, Duberstein PR, Hirsch JK, et al: Health status and suicide in the second half of life. Int J Geriatr Psychiatry 2010; 25:371–379
31.
Tang NK, Crane C: Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links. Psychol Med 2006; 36:575–586
32.
Hassett AL, Aquino JK, Ilgen MA: The risk of suicide mortality in chronic pain patients. Curr Pain Headache Rep 2014; 18:436
33.
Hooley JM, Franklin JC, Nock MK: Chronic pain and suicide: understanding the association. Curr Pain Headache Rep 2014; 18:435
34.
Arsenault-Lapierre G, Kim C, Turecki G: Psychiatric diagnoses in 3275 suicides: a meta-analysis. BMC Psychiatry 2004; 4:37
35.
Gvion Y, Apter A: Aggression, impulsivity, and suicide behavior: a review of the literature. Arch Suicide Res 2011; 15:93–112
36.
McGirr A, Turecki G: The relationship of impulsive aggressiveness to suicidality and other depression-linked behaviors. Curr Psychiatry Rep 2007; 9:460–466
37.
Conner KR, Conwell Y, Duberstein PR, et al: Aggression in suicide among adults age 50 and over. Am J Geriatr Psychiatry 2004; 12:37–42
38.
Fässberg MM, van Orden KA, Duberstein P, et al: A systematic review of social factors and suicidal behavior in older adulthood. Int J Environ Res Public Health 2012; 9:722–745
39.
Conner KR, Duberstein PR, Conwell Y, et al: Psychological vulnerability to completed suicide: a review of empirical studies. Suicide Life Threat Behav 2001; 31:367–385
40.
Brown GK, Green KL: High-risk cognitive states, in A Concise Guide to Understanding Suicide: Epidemiology, Pathophysiology and Prevention. Edited by Koslow SH, Ruiz P, Nemeroff CB. Cambridge, UK, Cambridge University Press, 2014, pp 42–51
41.
Beck AT, Steer RA, Kovacs M, et al: Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry 1985; 142:559–563
42.
Beck AT, Brown G, Berchick RJ, et al: Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiatry 1990; 147:190–195
43.
McAuliffe C, Keeley HS, Corcoran P: Problem solving and repetition of parasuicide. Behav Cogn Psychother 2002; 30:385–397
44.
Van Orden KA, Merrill KA, Joiner TE: Interpersonal-psychological precursors to suicidal behavior: a theory of attempted and completed suicide. Curr Psychiatr Rev 2005; 1:187–196
45.
Conner KR, Houston RJ, Swogger MT, et al: Stressful life events and suicidal behavior in adults with alcohol use disorders: role of event severity, timing, and type. Drug Alcohol Depend 2012; 120:155–161
46.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, Author, 1994
47.
González HM, Tarraf W, Whitfield KE, et al: The epidemiology of major depression and ethnicity in the United States. J Psychiatr Res 2010; 44:1043–1051
48.
Kendler KS, Thornton LM, Gardner CO: Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am J Psychiatry 2001; 158:582–586
49.
Kendler KS, Thornton LM, Gardner CO: Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the “kindling” hypothesis. Am J Psychiatry 2000; 157:1243–1251
50.
Monroe SM, Harkness KL: Life stress, the “kindling” hypothesis, and the recurrence of depression: considerations from a life stress perspective. Psychol Rev 2005; 112:417–445
51.
Binder EB, Nemeroff CB: The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol Psychiatry 2010; 15:574–588
52.
Hauger RL, Risbrough V, Oakley RH, et al: Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann N Y Acad Sci 2009; 1179:120–143
53.
McGuffin P, Knight J, Breen G, et al: Whole genome linkage scan of recurrent depressive disorder from the depression network study. Hum Mol Genet 2005; 14:3337–3345
54.
Sullivan PF, Neale MC, Kendler KS: Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000; 157:1552–1562
55.
Bradley RG, Binder EB, Epstein MP, et al: Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry 2008; 65:190–200
56.
Heim C, Newport DJ, Mletzko T, et al: The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 2008; 33:693–710
57.
Heim C, Bradley B, Mletzko TC, et al: Effect of childhood trauma on adult depression and neuroendocrine function: sex-specific moderation by CRH receptor 1 gene. Front Behav Neurosci 2009; 3:41
58.
Gatt JM, Nemeroff CB, Dobson-Stone C, et al: Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry 2009; 14:681–695
59.
Farmer AE, McGuffin P: Humiliation, loss and other types of life events and difficulties: a comparison of depressed subjects, healthy controls and their siblings. Psychol Med 2003; 33:1169–1175
60.
Friis RH, Wittchen HU, Pfister H, et al: Life events and changes in the course of depression in young adults. Eur Psychiatry 2002; 17:241–253
61.
Kendler KS, Hettema JM, Butera F, et al: Life event dimensions of loss, humiliation, entrapment, and danger in the prediction of onsets of major depression and generalized anxiety. Arch Gen Psychiatry 2003; 60:789–796
62.
Kendler KS, Karkowski LM, Prescott CA: Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 1999; 156:837–841
63.
Anderson RJ, Freedland KE, Clouse RE, et al: The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24:1069–1078
64.
Lin EH, Rutter CM, Katon W, et al: Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care 2010; 33:264–269
65.
Naranjo DM, Fisher L, Areán PA, et al: Patients with type 2 diabetes at risk for major depressive disorder over time. Ann Fam Med 2011; 9:115–120
66.
Almeida OP, Ford AH, Flicker L, et al: Angiogenesis inhibition and depression in older men. J Psychiatry Neurosci 2014; 39:200–205
67.
Ravven S, Bader C, Azar A, et al: Depressive symptoms after CABG surgery: a meta-analysis. Harv Rev Psychiatry 2013; 21:59–69
68.
Ayerbe L, Ayis S, Wolfe CD, et al: Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. Br J Psychiatry 2013; 202:14–21
69.
Leung YW, Flora DB, Gravely S, et al: The impact of premorbid and postmorbid depression onset on mortality and cardiac morbidity among patients with coronary heart disease: meta-analysis. Psychosom Med 2012; 74:786–801
70.
Meng L, Chen D, Yang Y, et al: Depression increases the risk of hypertension incidence: a meta-analysis of prospective cohort studies. J Hypertens 2012; 30:842–851
71.
Hung CI, Liu CY, Fuh JL, et al: Comorbid migraine is associated with a negative impact on quality of life in patients with major depression. Cephalalgia 2006; 26:26–32
72.
Breslau N, Schultz LR, Stewart WF, et al: Headache and major depression: is the association specific to migraine? Neurology 2000; 54:308–313
73.
Breslau N, Lipton RB, Stewart WF, et al: Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 2003; 60:1308–1312
74.
Sheftell FD, Atlas SJ: Migraine and psychiatric comorbidity: from theory and hypotheses to clinical application. Headache 2002; 42:934–944
75.
Medici M, Direk N, Visser WE, et al: Thyroid function within the normal range and the risk of depression: a population-based cohort study. J Clin Endocrinol Metab 2014; 99:1213–1219
76.
Ohayon MM, Lemoine P: Daytime consequences of insomnia complaints in the French general population. Encephale 2004; 30:222–227
77.
Zarrouf FA, Artz S, Griffith J, et al: Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract 2009; 15:289–305
78.
Yeap BB: Hormonal changes and their impact on cognition and mental health of ageing men. Maturitas 2014; 79:227–235
79.
Khera M: Patients with testosterone deficit syndrome and depression. Arch Esp Urol 2013; 66:729–736
80.
Luppino FS, de Wit LM, Bouvy PF, et al: Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67:220–229
81.
Göthe F, Enache D, Wahlund LO, et al: Cerebrovascular diseases and depression: epidemiology, mechanisms and treatment. Panminerva Med 2012; 54:161–170
82.
Naarding P, Beekman AT: Vascular depression: where do we go from here? Expert Rev Neurother 2011; 11:77–83
83.
Djamshidian A, Friedman JH: Anxiety and depression in Parkinson’s disease. Curr Treat Options Neurol 2014; 16:285
84.
Raskind MA: Diagnosis and treatment of depression comorbid with neurologic disorders. Am J Med 2008; 121(Suppl 2):S28–S37
85.
Atkinson JH, Slater MA, Patterson TL, et al: Prevalence, onset, and risk of psychiatric disorders in men with chronic low back pain: a controlled study. Pain 1991; 45:111–121
86.
Fishbain DA, Cutler R, Rosomoff HL, et al: Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 1997; 13:116–137
87.
Wilson KG, Eriksson MY, D’Eon JL, et al: Major depression and insomnia in chronic pain. Clin J Pain 2002; 18:77–83
88.
Campbell LC, Clauw DJ, Keefe FJ: Persistent pain and depression: a biopsychosocial perspective. Biol Psychiatry 2003; 54:399–409
89.
McWilliams LA, Cox BJ, Enns MW: Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain 2003; 106:127–133
90.
Cottler LB, Ben Abdallah A, Cummings SM, et al: Injury, pain, and prescription opioid use among former National Football League (NFL) players. Drug Alcohol Depend 2011; 116:188–194
91.
Schwenk TL, Gorenflo DW, Dopp RR, et al: Depression and pain in retired professional football players. Med Sci Sports Exerc 2007; 39:599–605
92.
Banks SM, Kerns RD: Explaining high rates of depression in chronic pain: a diathesis-stress framework. Psychol Bull 1996; 119:95–110
93.
Ilgen MA, Zivin K, McCammon RJ, et al: Pain and suicidal thoughts, plans and attempts in the United States. Gen Hosp Psychiatry 2008; 30:521–527
94.
McCarthy TC: Life after football. Newsday 2015 (data.newsday.com/projects/sports/football/life-football/)
95.
Kreutzer JS, Seel RT, Gourley E: The prevalence and symptom rates of depression after traumatic brain injury: a comprehensive examination. Brain Inj 2001; 15:563–576
96.
Seel RT, Kreutzer JS, Rosenthal M, et al: Depression after traumatic brain injury: a National Institute on Disability and Rehabilitation Research Model Systems multicenter investigation. Arch Phys Med Rehabil 2003; 84:177–184
97.
Silver JM, Kramer R, Greenwald S, et al: The association between head injuries and psychiatric disorders: findings from the New Haven NIMH Epidemiologic Catchment Area Study. Brain Inj 2001; 15:935–945
98.
Mooney G, Speed J: The association between mild traumatic brain injury and psychiatric conditions. Brain Inj 2001; 15:865–877
99.
Levin HS, McCauley SR, Josic CP, et al: Predicting depression following mild traumatic brain injury. Arch Gen Psychiatry 2005; 62:523–528
100.
Levin HS, Brown SA, Song JX, et al: Depression and posttraumatic stress disorder at three months after mild to moderate traumatic brain injury. J Clin Exp Neuropsychol 2001; 23:754–769
101.
Mackelprang JL, Bombardier CH, Fann JR, et al: Rates and predictors of suicidal ideation during the first year after traumatic brain injury. Am J Public Health 2014; 104:e100–e107
102.
Ventura T, Harrison-Felix C, Carlson N, et al: Mortality after discharge from acute care hospitalization with traumatic brain injury: a population-based study. Arch Phys Med Rehabil 2010; 91:20–29
103.
Simpson G, Tate R: Suicidality in people surviving a traumatic brain injury: prevalence, risk factors and implications for clinical management. Brain Inj 2007; 21:1335–1351
104.
Fazel S, Wolf A, Pillas D, et al: Suicide, fatal injuries, and other causes of premature mortality in patients with traumatic brain injury: a 41-year Swedish population study. JAMA Psychiatry 2014; 71:326–333
105.
Olin JT, Schneider LS, Katz IR, et al: Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry 2002; 10:125–128
106.
Steinberg M, Shao H, Zandi P, et al: Cache County Investigators: Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry 2008; 23:170–177
107.
Bruce JM, Bhalla R, Westervelt HJ, et al: Neuropsychological correlates of self-reported depression and self-reported cognition among patients with mild cognitive impairment. J Geriatr Psychiatry Neurol 2008; 21:34–40
108.
Barnes DE, Alexopoulos GS, Lopez OL, et al: Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry 2006; 63:273–279
109.
Kosteniuk JG, Morgan DG, O’Connell ME, et al: Prevalence and covariates of elevated depressive symptoms in rural memory clinic patients with mild cognitive impairment or dementia. Dement Geriatr Cogn Dis Extra 2014; 4:209–220
110.
Modrego PJ, Ferrández J: Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol 2004; 61:1290–1293
111.
Richard E, Reitz C, Honig LH, et al: Late-life depression, mild cognitive impairment, and dementia. JAMA Neurol 2013; 70:374–382
112.
Mackin RS, Insel P, Aisen PS, et al: Alzheimer’s Disease Neuroimaging Initiative: Longitudinal stability of subsyndromal symptoms of depression in individuals with mild cognitive impairment: relationship to conversion to dementia after 3 years. Int J Geriatr Psychiatry 2012; 27:355–363
113.
Van der Mussele S, Fransen E, Struyfs H, et al: Depression in mild cognitive impairment is associated with progression to Alzheimer’s disease: a longitudinal study. J Alzheimers Dis 2014; 42:1239–1250
114.
Palmer K, Di Iulio F, Varsi AE, et al: Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer’s disease: the role of depression and apathy. J Alzheimers Dis 2010; 20:175–183
115.
Lee GJ, Lu PH, Hua X, et al: Alzheimer’s Disease Neuroimaging Initiative: Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer’s disease-related regions. Biol Psychiatry 2012; 71:814–821
116.
Diamond J: The Irritable Male Syndrome: Understanding and Managing the 4 Key Causes of Depression and Aggression. New York, Rodale, Inc., 2005
117.
Pollack WS, Levant RF: New Psychotherapy for Men. New York, John Wiley & Sons, Inc., 1998
118.
Busch FN: Anger and depression. Adv Psychiatr Treat 2009; 15:271–278
119.
Fava M, Hwang I, Rush AJ, et al: The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey Replication. Mol Psychiatry 2010; 15:856–867
120.
Perlis RH, Fava M, Trivedi MH, et al: Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder. Acta Psychiatr Scand 2009; 119:282–289
121.
Winkler D, Pjrek E, Kasper S: Anger attacks in depression--evidence for a male depressive syndrome. Psychother Psychosom 2005; 74:303–307
122.
Martin LA, Neighbors HW, Griffith DM: The experience of symptoms of depression in men vs women: analysis of the National Comorbidity Survey Replication. JAMA Psychiatry 2013; 70:1100–1106
123.
Breslau N, Davis GC, Schultz LR, et al: Joint 1994 Wolff Award Presentation. Migraine and major depression: a longitudinal study. Headache 1994; 34:387–393
124.
Bodenmann G, Randall AK: Close relationships in psychiatric disorders. Curr Opin Psychiatry 2013; 26:464–467
125.
Jaremka LM, Lindgren ME, Kiecolt-Glaser JK: Synergistic relationships among stress, depression, and troubled relationships: insights from psychoneuroimmunology. Depress Anxiety 2013; 30:288–296
126.
Bulloch AG, Williams JV, Lavorato DH, et al: The relationship between major depression and marital disruption is bidirectional. Depress Anxiety 2009; 26:1172–1177
127.
Bulloch A, Lavorato D, Williams J, et al: Alcohol consumption and major depression in the general population: the critical importance of dependence. Depress Anxiety 2012; 29:1058–1064
128.
Cheng Q, Li H, Silenzio V, et al: Suicide contagion: a systematic review of definitions and research utility. PLoS One 2014; 9:e108724
129.
Lee AR, Ahn MH, Lee TY, et al: Rapid spread of suicide by charcoal burning from 2007 to 2011 in Korea. Psychiatry Res 2014; 219:518–524
130.
Ju Ji N, Young Lee W, Seok Noh M, et al: The impact of indiscriminate media coverage of a celebrity suicide on a society with a high suicide rate: epidemiological findings on copycat suicides from South Korea. J Affect Disord 2014; 156:56–61
131.
Yang AC, Tsai SJ, Yang CH, et al: Suicide and media reporting: a longitudinal and spatial analysis. Soc Psychiatry Psychiatr Epidemiol 2013; 48:427–435
132.
Sisask M, Värnik A: Media roles in suicide prevention: a systematic review. Int J Environ Res Public Health 2012; 9:123–138
133.
Davis DS: Alzheimer disease and pre-emptive suicide. J Med Ethics 2014; 40:543–549
134.
Draper B, Peisah C, Snowdon J, et al: Early dementia diagnosis and the risk of suicide and euthanasia. Alzheimers Dement 2010; 6:75–82
135.
Mormont E, Jamart J, Jacques D: Symptoms of depression and anxiety after the disclosure of the diagnosis of Alzheimer disease. J Geriatr Psychiatry Neurol 2014; 27:231–236
136.
Simmons RD: Life issues in multiple sclerosis. Nat Rev Neurol 2010; 6:603–610
137.
Jopson NM, Moss-Morris R: The role of illness severity and illness representations in adjusting to multiple sclerosis. J Psychosom Res 2003; 54:503–511, discussion 513–514
138.
Halpin M: Accounts of suicidality in the Huntington disease community. Omega (Westport) 2012; 65:317–334
139.
Blosnich J, Bossarte R: Suicide acceptability among U.S. Veterans with active duty experience: results from the 2010 General Social Survey. Arch Suicide Res 2013; 17:52–57
140.
Weir DR, Jackson JS, Sonnega A: National Football League Player Care Foundation: Study of Retired NFL Players. Ann Arbor, University of Michigan Institute for Social Research, 2009
Information & Authors
Information
Published In
History
Received: 11 July 2015
Revision received: 2 August 2015
Accepted: 6 August 2015
Published online: 9 October 2015
Published in print: Winter 2016
Authors
Funding Information
Dr. Iverson has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mild traumatic brain injury and sports-related concussion at meetings, scientific conferences, and symposiums. He has a clinical and consulting practice in forensic neuropsychology involving individuals who have sustained mild traumatic brain injuries (including professional athletes). He has been a principal investigator and coinvestigator on federal and industry grants on topics relating to mild traumatic brain injury, neuropsychological assessment, and depression. He receives royalties for books and for one neuropsychological test.
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
PDF/EPUB
View PDF/EPUBLogin options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).